EC Approves Mylan-Pfizer Merger 'With Conditions'

GALWAY, IRELAND--May 5, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--The proposed multibillion-dollar merger of Pfizer (NYSE:PFE) (New York, New York) and Mylan's (NASDAQ:MYL) (Canonsburg, Pennsylvania) generics drugs businesses into a new company has received a conditional green light from the European Commission (EC).

Within this article: Details progress of merger, EC approval with conditions, estimated completion date